FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033006779> ?p ?o ?g. }

• W3033006779 endingPage "127" @default.
• W3033006779 startingPage "113" @default.
• W3033006779 abstract "Abstract N-cadherin is a transmembrane glycoprotein expressed by mesenchymal origin cells and is located at the adherens junctions. It regulates also cell motility and contributes to cell signaling. In previous studies, we identified that its anomalous expression in bladder carcinoma was a tumor progression marker. A pharmacological approach to inhibit N-cadherin expression or to block its function could be relevant to prevent disease progression and metastasis development. The morphological exploration of T24 invasive bladder cancer cells by atomic force microscopy (AFM) revealed a spindle-like shape with fibrous structures. By engaging force spectroscopy with AFM tip functionalized with anti-E or anti-N-cadherin antibodies, results showed that T24 cells expressed only N-cadherin as also demonstrated by Western blotting and confocal microscopy. For the first time, we demonstrated by RTqPCR and Western blotting analyses that the peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 significantly decreased N-cadherin expression in T24 cells. Moreover, high non-cytotoxic doses of GW501516 inhibited confluent T24 cell wound healing closure. By using AFM, a more sensitive nanoanalytical method, we showed that the treatment modified the cellular morphology and diminished N-cadherin cell surface coverage through the decreasing of these adhesion molecule-mediated interaction forces. We observed a greater decrease of N-cadherin upon GW501516 exposure with AFM than that detected with molecular biology techniques. AFM was a complementary tool to biochemical techniques to perform measurements on living cells at the nanometer resolution level. Taken together, our data suggest that GW501516 could be an interesting therapeutic strategy to avoid bladder cancer cell spreading through N-cadherin decrease." @default.
• W3033006779 created "2020-06-12" @default.
• W3033006779 creator A5021987605 @default.
• W3033006779 creator A5026741435 @default.
• W3033006779 creator A5046458276 @default.
• W3033006779 creator A5048998029 @default.
• W3033006779 creator A5083648477 @default.
• W3033006779 date "2020-06-09" @default.
• W3033006779 modified "2023-09-25" @default.
• W3033006779 title "Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure" @default.
• W3033006779 cites W1813874230 @default.
• W3033006779 cites W1979761686 @default.
• W3033006779 cites W1981538228 @default.
• W3033006779 cites W1981723630 @default.
• W3033006779 cites W1981824310 @default.
• W3033006779 cites W1985688210 @default.
• W3033006779 cites W1988499895 @default.
• W3033006779 cites W2002045993 @default.
• W3033006779 cites W2017671227 @default.
• W3033006779 cites W2019135895 @default.
• W3033006779 cites W2031269694 @default.
• W3033006779 cites W2035297454 @default.
• W3033006779 cites W2051471339 @default.
• W3033006779 cites W2060736784 @default.
• W3033006779 cites W2065093481 @default.
• W3033006779 cites W2070729831 @default.
• W3033006779 cites W2073052482 @default.
• W3033006779 cites W2091242342 @default.
• W3033006779 cites W2093594164 @default.
• W3033006779 cites W2099153170 @default.
• W3033006779 cites W2101045288 @default.
• W3033006779 cites W2105209624 @default.
• W3033006779 cites W2108244474 @default.
• W3033006779 cites W2109599176 @default.
• W3033006779 cites W2127658932 @default.
• W3033006779 cites W2127920357 @default.
• W3033006779 cites W2144340025 @default.
• W3033006779 cites W2151781453 @default.
• W3033006779 cites W2161728771 @default.
• W3033006779 cites W2171889834 @default.
• W3033006779 cites W2204222147 @default.
• W3033006779 cites W2293838607 @default.
• W3033006779 cites W2520032427 @default.
• W3033006779 cites W2594461205 @default.
• W3033006779 cites W2602079860 @default.
• W3033006779 cites W2748271565 @default.
• W3033006779 cites W2761973325 @default.
• W3033006779 cites W2800702047 @default.
• W3033006779 cites W2807329428 @default.
• W3033006779 cites W2889646458 @default.
• W3033006779 cites W2891160726 @default.
• W3033006779 cites W2912602247 @default.
• W3033006779 cites W2979836143 @default.
• W3033006779 doi "https://doi.org/10.1007/s11010-020-03771-1" @default.
• W3033006779 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7370938" @default.
• W3033006779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32519230" @default.
• W3033006779 hasPublicationYear "2020" @default.
• W3033006779 type Work @default.
• W3033006779 sameAs 3033006779 @default.
• W3033006779 citedByCount "10" @default.
• W3033006779 countsByYear W30330067792020 @default.
• W3033006779 countsByYear W30330067792021 @default.
• W3033006779 countsByYear W30330067792022 @default.
• W3033006779 countsByYear W30330067792023 @default.
• W3033006779 crossrefType "journal-article" @default.
• W3033006779 hasAuthorship W3033006779A5021987605 @default.
• W3033006779 hasAuthorship W3033006779A5026741435 @default.
• W3033006779 hasAuthorship W3033006779A5046458276 @default.
• W3033006779 hasAuthorship W3033006779A5048998029 @default.
• W3033006779 hasAuthorship W3033006779A5083648477 @default.
• W3033006779 hasBestOaLocation W30330067791 @default.
• W3033006779 hasConcept C104317684 @default.
• W3033006779 hasConcept C121608353 @default.
• W3033006779 hasConcept C1491633281 @default.
• W3033006779 hasConcept C149402561 @default.
• W3033006779 hasConcept C185592680 @default.
• W3033006779 hasConcept C502942594 @default.
• W3033006779 hasConcept C54355233 @default.
• W3033006779 hasConcept C55493867 @default.
• W3033006779 hasConcept C85265743 @default.
• W3033006779 hasConcept C85789140 @default.
• W3033006779 hasConcept C86803240 @default.
• W3033006779 hasConcept C95444343 @default.
• W3033006779 hasConcept C96232424 @default.
• W3033006779 hasConceptScore W3033006779C104317684 @default.
• W3033006779 hasConceptScore W3033006779C121608353 @default.
• W3033006779 hasConceptScore W3033006779C1491633281 @default.
• W3033006779 hasConceptScore W3033006779C149402561 @default.
• W3033006779 hasConceptScore W3033006779C185592680 @default.
• W3033006779 hasConceptScore W3033006779C502942594 @default.
• W3033006779 hasConceptScore W3033006779C54355233 @default.
• W3033006779 hasConceptScore W3033006779C55493867 @default.
• W3033006779 hasConceptScore W3033006779C85265743 @default.
• W3033006779 hasConceptScore W3033006779C85789140 @default.
• W3033006779 hasConceptScore W3033006779C86803240 @default.
• W3033006779 hasConceptScore W3033006779C95444343 @default.
• W3033006779 hasConceptScore W3033006779C96232424 @default.
• W3033006779 hasIssue "1-2" @default.

• next